-
Mashup Score: 9Depression Biomarker Enables Precision Therapy in Landmark Study - 3 year(s) ago
A new way of treating major depression has been developed by scientists at the University of California San Francisco (UCSF). The approach builds on earlier work that identified signature electrical activities in the brain that correlate to different moods, and brain regions that when stimulated relieve depression. In the new two-step method, the researchers identify a symptom-specific neural…
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 18
Women with postpartum depression experience smell differently than other women, a University of Otago study has found.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 11Roots of major depression revealed in all its genetic complexity - 3 year(s) ago
A massive genome-wide association study (GWAS) of genetic and health records of 1.2 million people from four separate data banks has identified 178 gene variants linked to major depression, a disorder that will affect one of every five people during their lifetimes.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Faith and ScienceAcknowledgement of the importance of religion and spirituality in medicine is increasing. Several studies have shown a predominantly inverse relationship between faith-based activities and psychiatric disorders.1 Chronic stress alters autonomic nervous system reactivity, and changes in the dopamine systems of people undergoing chronic stress have been well documented in the…
Source: SAGE JournalsCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 10
Using machine learning, researchers have identified novel, distinct patterns of coordinated activity between different parts of the brain in people with major depressive disorder—even when different protocols are used to detect these brain networks. Ayumu Yamashita of Advanced Telecommunications Research Institutes International in Kyoto, Japan, and colleagues present these findings in the…
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 8
In a small study of adults with major depression, Johns Hopkins Medicine researchers report that two doses of the psychedelic substance psilocybin, given with supportive psychotherapy, produced rapid and large reductions in depressive symptoms, with most participants showing improvement and half of study participants achieving remission through the four-week follow-up.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet
Depression Biomarker Enables Precision Therapy in Landmark Study A new way of treating #majordepression has been developed by scientists at the University of California San Francisco @UCSF. Learn more: https://t.co/9DqWhqHwJu https://t.co/0gRBlsnyd4